Tackling antimicrobial resistance in cancer patients at the Christie NHS Foundation Trust

Antimicrobial resistant (AMR) infections are estimated to cause 700,000 deaths each year globally, and this figure is predicted to rise to 10 million with a cumulative cost of US$100tn by 2050
Source: The Pharmaceutical Journal - Category: Drugs & Pharmacology Source Type: research